Clinical Trials on Subjective Memory Impairment in Poland

Total 140 results

Otonomy, Inc.

Completed

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Subjective Tinnitus

United States, United Kingdom, Germany, Poland
Epizyme, Inc.
Sponsor GmbH

Recruiting

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Hepatic Impairment | Advanced Malignant Solid Tumor

France, Belgium, United States, Poland, Slovakia
Vivoryon Therapeutics N.V.
Amsterdam UMC, location VUmc; Nordic Bioscience A/S

Completed

A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD (VIVIAD)

Early Alzheimers Disease | Mild Cognitive Impairment Due to AD

Netherlands, Spain, Denmark, Germany, Poland
AstraZeneca

Completed

Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment

Renal Impairment

United States
Merz Pharmaceuticals GmbH

Terminated

Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus (OLLTT)

Subjective Tinnitus

United States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
The Miriam Hospital
National Institute on Aging (NIA)

Recruiting

Mind Your Heart-II (MYH-II)

Heart Failure | Cognitive Impairment

United States
Oregon Health and Science University

Recruiting

Neighborhood-based Physical and Social Activity for Older Black Caregivers and People Living With Dementia (SHARP-CG)

Depression | Cognitive Impairment | Caregiver Burden

United States
US Department of Veterans Affairs

Completed

The Performance-Perceptual Test as a Counseling Tool (PPT)

Hearing Impairment

United States
Astellas Pharma Inc

Completed

Renal Impairment Study With ASP1941

Type 2 Diabetes Mellitus

Hungary, Poland, Czechia, Slovakia
HealthPartners Institute
National Institute on Aging (NIA); OCHIN, Inc.

Recruiting

A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment (CI Wizard)

Cognitive Impairment | Dementia

United States
BioSpeech
Oregon Health and Science University

Completed

Audiobooks for Hearing Loss App as Auditory Training

Hearing Loss | Hearing Impairment | Hearing Impaired Children

United States
Merz Pharmaceuticals GmbH

Completed

Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

Subjective Tinnitus

United States, Austria, Germany, Brazil, Mexico
Ipsen

Completed

A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke

Stroke, Acute | Neurological Impairment

Czechia, Poland, Romania, Russian Federation
VU University of Amsterdam

Completed

Effectiveness of the Serious Game 'Broodles' for Siblings of Children With Visual Impairment and/or Intellectual Disability

Healthy

Netherlands
Amsterdam UMC, location VUmc

Not yet recruiting

Memory Enhancement Using Transcranial Alternating Current Stimulation (Memento)

Alzheimer Disease | Mild Cognitive Impairment

Netherlands
Zydus Therapeutics Inc.

Recruiting

A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects With Severe Renal Impairment and Normal Renal Function

Renal Impairment

United States
Boehringer Ingelheim

Completed

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Arthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)

Austria, Canada, Czechia, Finland, Netherlands, Sweden
Oregon Health and Science University
National Institute on Aging (NIA)

Completed

Conversations as a Means to Delay the Onset of Alzheimer's Disease (conversation)

Cognitive Change | Mild Cognitive Impairment

United States
PRInnovation GmbH
Julius Clinical; Federal Agency for Disruptive Innovation - SPRIN-D; Priavoid

Recruiting

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease, Early Onset

Spain, Germany, Italy, Czechia, Netherlands, Poland
NICHD Neonatal Research Network
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants (Darbe)

Neonatal | Neurodevelopmental Impairment | Neurocognitive | Neuroprotective

United States
Oregon Health and Science University

Recruiting

OCT Angiography and NRAI in Dementia

Dementia | Alzheimer Disease | Mild Cognitive Impairment

United States
Erasmus Medical Center

Completed

Resuscitation Outcomes in the Netherlands (ROUTiNE)

Quality of Life | Cognitive Impairment | Heart Arrest | Cardiac Arrest | Outcome, Fatal | Cardiac Arrest as A Complication of Care

Netherlands
Butler Hospital
Brown University; The Miriam Hospital; Alzheimer's Association

Recruiting

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD (LINE-AD)

Mild Cognitive Impairment | Alzheimer Disease, Early Onset | Moderate Dementia

United States
Eisai Inc.

Completed

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Butler Hospital
Eli Lilly and Company; GE Healthcare; Hoffmann-La Roche; Brown University; University... and other collaborators

Recruiting

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

Dementia | Alzheimer Disease | Mild Cognitive Impairment

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Mild Cognitive Impairment

United States, United Kingdom, Belgium, Germany, Spain, Argentina, Israel, Poland, Australia, Canada, Netherlands, Finland, Austria, Sweden, France, Czech Republic
University of Pennsylvania
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood (RESTORE-cog)

Intellectual Disability | Perceptual Disorders | Memory Disorders

United States
Oregon Health and Science University
National Multiple Sclerosis Society

Completed

Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis

Multiple Sclerosis | Cognition

United States
University of Southern California
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Wake Forest University Health Sciences

Completed

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment

United States
Ascelia Pharma AB

Completed

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (SPARKLE)

Severe Renal Impairment | Known or Suspected Focal Liver Lesions

United States, Italy, Germany, Poland, Russian Federation, Sweden, Turkey, Argentina, Colombia, Mexico
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Recruiting

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) (ADNI3)

Mild Cognitive Impairment (MCI) | Alzheimer's Disease (AD)

United States, Canada
National Institute on Aging (NIA)

Completed

Alzheimer's Disease Prevention Trial

Alzheimer Disease | Memory Disorders

United States
Pfizer

Completed

Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532

Healthy | Type 2 Diabetes Mellitus

United States
Ronak Delewi

Recruiting

Cardiac Output, Cerebral Perfusion and Cognition in Patients Undergoing TAVI (CAPITA)

Cognitive Impairment | Aortic Valve Stenosis | Cognitive Change

Netherlands
Takeda
Zinfandel Pharmaceuticals Inc.

Terminated

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset (TOMMORROW)

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Germany, Switzerland, United Kingdom, Australia
Astellas Pharma Global Development, Inc.

Completed

A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Renal Impairment | Healthy Volunteers

United States
Oncopeptides AB

Terminated

PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function (BRIDGE)

Multiple Myeloma | Renal Impairment

Greece, Czechia, Poland
VA Office of Research and Development

Completed

Blast Exposed Veterans With Auditory Complaints

Hearing Impairment | Hearing Aid Fitting

United States
Vertex Pharmaceuticals Incorporated

Completed

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Pain

United States
University of Rhode Island
Stuart Sinoff, MD; Peter J Snyder, MD; BayCare Health System

Recruiting

Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)

Cognitive Change | Alzheimer Disease | Aging | Mild Cognitive Impairment | Mild Dementia

United States
Helius Medical Inc

Recruiting

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) (PoNSTEP)

Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)

United States
Eli Lilly and Company

Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Mild Cognitive Impairment (MCI) | Alzheimer Disease

United States
Takeda

Completed

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

Gout | Moderate Renal Impairment

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.; National Institutes of Health... and other collaborators

Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy (AL)

Visual Impairment | Radiation Retinopathy

United States
Baylor Research Institute

Recruiting

Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement (Neurcog TAVR)

Aortic Stenosis | Mild Cognitive Impairment

United States
Oregon Health and Science University

Completed

Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments (MSPi)

Cerebral Palsy | Physical Impairments | Cerebral Ataxia | locked-in Syndrome

United States
Oregon Health and Science University
University of Southern California; Forest Laboratories; University of Texas Southwestern... and other collaborators

Completed

Trial of Memantine for Cognitive Impairment in Multiple Sclerosis

Multiple Sclerosis | Cognition Disorders

United States
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, Australia, Italy, United States, Spain, Denmark, United Kingdom, Czechia, France, Poland, Canada, Switzerland, Germany, Japan, Finland, Netherlands, Sweden
Eli Lilly and Company

Completed

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Brain Diseases | Central Nervous System Diseases | Cognitive Impairment | Dementia | Alzheimer Disease

United States, Canada
Oregon Health and Science University
United States Department of Defense

Recruiting

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation (SuBTyPE)

Rehabilitation | Mild Traumatic Brain Injury, Concussion | Balance Impairment

United States

Clinical Trials on Subjective Memory Impairment in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations